GlassScriptPhysician profile
Mohammad Yusuf Hanif
NPI 1851701296
$1,416.22
in general payments reported to CMS, 2019-2025
17 companies · $579 in 2025
The $579 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $331 · 2024: $401 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $447.64 | 2022-2025 | Spravato |
| Abbvie INC. | $291.44 | 2022-2024 | |
| Intra-Sana Laboratories | $120.06 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Ucb, INC. | $101.43 | 2024-2025 | Briviact |
| Exact Sciences Corporation | $78.82 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tris Pharma INC | $53.85 | 2025 | Dyanavel Xr |
| Medtronic, INC. | $48.76 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Pfizer INC. | $44.04 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $35.60 | 2024 | Acthar |
| Neurocrine Biosciences, INC. | $30.57 | 2025 | |
| Neurelis, INC. | $28.56 | 2025 | Valtoco |
| Merz North America, INC. | $25.76 | 2025 | |
| Tolmar, INC. | $24.80 | 2025 | Jatenzo |
| Corium, LLC | $23.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.25 | 2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.93 | 2025 | Trintellix |
| Biomerieux INC | $19.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.